SCHEMBL27626895

SCHEMBL27626895

O=C(C(CBr)c1cccnc1)C(CBr)c1cccnc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ TBXAS1 P24557 3/20 0.44
▸ CFTR P13569 1/20 0.44
▸ SLC6A2 P23975 1/20 0.44
▸ SLC6A4 P31645 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.44
▸ GOPC Q9HD26 1/20 0.44
▸ GAA P10253 2/20 0.41
▸ THRB P10828 1/20 0.41
▸ NAPRT Q6XQN6 1/20 0.41
▸ EPHX2 P34913 2/20 0.40
▸ HPGD P15428 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ APP P05067 1/20 0.40
▸ HCAR3 P49019 1/20 0.40
▸ HCAR2 Q8TDS4 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL27692435 0.98 SMN1; SMN2 (0.46) SMN1; SMN2LMNAL3MBTL1TBXAS1CFTR
SCHEMBL28803513 0.82 SMN1; SMN2 (0.47) SMN1; SMN2LMNAL3MBTL1TBXAS1CFTR
Hydrochloric Acid SCHEMBL27645555 0.81 SMN1; SMN2 (0.46) SMN1; SMN2LMNAL3MBTL1TBXAS1CFTR
SCHEMBL235125 0.77 SMN1; SMN2 (0.50) SMN1; SMN2LMNAL3MBTL1TBXAS1CFTR
SCHEMBL29852444 0.77 SMN1; SMN2 (0.50) SMN1; SMN2LMNAL3MBTL1TBXAS1CFTR
SCHEMBL6075149 0.77 SMN1; SMN2 (0.57) SMN1; SMN2LMNAL3MBTL1CFTRSLC6A2
SCHEMBL6307776 0.77 SMN1; SMN2 (0.57) SMN1; SMN2LMNAL3MBTL1CFTRSLC6A2
SCHEMBL27561149 0.77 LMNA (0.42) SMN1; SMN2LMNASLC6A2SLC6A4SLC6A3
SCHEMBL4476838 0.77 SMN1; SMN2 (0.57) SMN1; SMN2LMNAL3MBTL1CFTRSLC6A2
SCHEMBL29963731 0.77 TBXAS1 (0.47) SMN1; SMN2LMNAL3MBTL1TBXAS1CFTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110225912-A GSK-3 inhibitor 百时美施贵宝公司 2019-09-10 — — CN disclosed
CN-104781254-B Can as kinase modulator through the substituted pyridinyl compounds of heteroaryl 百时美施贵宝公司 2016-12-14 — — CN disclosed
CN-103342701-B Thiazolamine compound polymorphic as inhibitors of kinases and preparation method thereof AB科学有限公司 2016-09-21 — — CN disclosed
CN-104093308-A Pesticidal compositions and processes related thereto DOW AGROSCIENCES LLC 2014-10-08 — — CN disclosed
CN-103957908-A Substituted aminothiazoles as inhibitors of cancer including hepatocellular carcinoma and as inhibitors of hepatitis virus replication INST HEPATITIS & VIRUS RES 2014-07-30 — — CN disclosed
CN-103342701-A 2-Aminothiazole compound polycrystalline type as kinase inhibitors and preparation method thereof AB SCIENCE 2013-10-09 — — CN disclosed
CN-101657446-B Method for synthesizing 2-aminothiazole compounds as kinase inhibitors AB SCIENCE 2013-05-15 — — CN disclosed
CN-101679404-B Piperidine-amide derivatives HOFFMANN LA ROCHE 2012-06-13 — — CN disclosed
CN-102123987-A Cycloalkylidene and heterocycloalkylidene histone deacetylase inhibitor compounds GILEAD COLORADO INC 2011-07-13 — — CN disclosed
CN-101006082-B Histamine H3 receptor agents, methods of preparation and therapeutic uses LILLY CO ELI 2010-09-29 — — CN disclosed
CN-101679404-A piperidine-amide derivatives HOFFMANN LA ROCHE 2010-03-24 — — CN disclosed
CN-101657446-A Method for synthesizing 2-aminothiazole compounds as kinase inhibitors SCIENCE FR AB 2010-02-24 — — CN disclosed
CN-100381429-C Thiazole derivatives HOFFMANN LA ROCHE (CH) 2008-04-16 — — CN disclosed
CN-101006082-A Histamine H3 receptor agents, methods of preparation and therapeutic uses LILLY CO ELI (US) 2007-07-25 — — CN disclosed
CN-1980906-A Compounds and compositions as PPAR modulators IRM LLC (BM) 2007-06-13 — — CN disclosed
CN-1930144-A 3-'4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases BOEHRINGER INGELHEIM PHARMA (US) 2007-03-14 — — CN disclosed
CN-1675188-A Thiazole derivatives HOFFMANN LA ROCHE (CH) 2005-09-28 — — CN disclosed
Send feedback